US approves Alzheimer’s drug that can slow disease’s progress
US health officials have approved a drug that has been shown to slow the early stages of Alzheimer’s disease.
The drug, Leqembi, can make a modest impact on the progress of the degenerative brain disease, but it also comes with potential safety risks that doctors and patients will have to carefully weigh.
